Thus, CLDN1 behaves as a metastasis suppressor and chemo-sensitizer in breast cancer: its absence promotes EMT and invasion, while its expression helps maintain epithelial adhesion and chemosensitivity (85). Here, CLDN1 is linked to breast carcinoma.